| abstract |
The present invention relates to the use of tetramisole or its derivatives as an active agent, in a composition, a biocidal formulation and in methods, for preventing or treating of disease, such as anthrax, caused by a spore producing microorganism, such as Bacillus anthracis, in a human, or in the prevention or inhibition of the growth of such a spore producing microorganism in a human or for inhibiting the biological activity of the spore producing microorganism in a selected area, such as a post office. |